India’s health regulator has approved Eli Lilly’s pre-filled pen version of Mounjaro, expanding its availability across six dosage strengths. The once-weekly injector, known as Mounjaro KwikPen, now covers doses ranging from 2.

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, intensifying the race for India's booming obesity drug market.

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on meeting demand for the drug in the world's most populous country.